Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-01 6:30 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 9,986,556 9.9% | -31,519 (-0.31%) | View |
| 2024-03-27 4:37 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 10,018,075 9.9% | -13,061,066 (-56.59%) | View |
| 2024-02-16 6:55 pm Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 23,079,141 18.89% | 3,116,577 (+15.61%) | View |
| 2024-02-14 8:33 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II L.P. | 9,038,844 9.99% | 1,729,716 (+23.67%) | View |
| 2024-02-14 5:01 pm Sale | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 0 0% | -5,999,481 (Position Closed) | View |
| 2024-02-14 4:11 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management L.P. | 5,243,623 6.1% | 1,680,721 (+47.17%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 6,172,086 7.1% | 1,246,086 (+25.30%) | View |
| 2024-02-14 12:51 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Kynam Capital Management LP | 5,854,766 6.8% | 5,854,766 (New Position) | View |
| 2024-02-13 5:02 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | VANGUARD GROUP INC | 4,534,655 5.27% | 4,534,655 (New Position) | View |
| 2024-02-09 4:22 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 5,631,042 6.5% | 2,000,000 (+55.08%) | View |
| 2024-02-09 08:50 am Purchase | 13G | COGENT BIOSCIENCES INC COGT | FMR LLC | 5,302,854 6.157% | 5,302,854 (New Position) | View |
| 2024-02-05 4:43 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | SUVRETTA CAPITAL MANAGEMENT LLC | 5,481,034 6.4% | 5,481,034 (New Position) | View |
| 2024-01-26 11:49 am Purchase | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 6,755,584 7.8% | 1,809,141 (+36.57%) | View |
| 2024-01-23 09:01 am Sale | 13G | COGENT BIOSCIENCES INC COGT | STATE STREET CORP STT | 4,150,615 4.82% | -110,766 (-2.60%) | View |
| 2023-06-13 4:06 pm Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 19,962,564 19.99% | 4,732,091 (+31.07%) | View |
| 2023-06-01 5:00 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management L.P. | 3,562,902 5% | 3,562,902 (New Position) | View |
| 2023-02-14 4:55 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II L.P. | 7,309,128 9.99% | 3,007,002 (+69.90%) | View |
| 2023-02-14 4:45 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 5,999,481 8.6% | 2,387,274 (+66.09%) | View |
| 2023-02-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 4,926,000 7% | 2,644,685 (+115.93%) | View |
| 2023-02-14 2:23 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 3,631,042 5.2% | 3,631,042 (New Position) | View |